RecallDepth
Class II Ongoing

Levothyroxine Sodium Tablets, USP, 88 mcg (0.088 mg), 90 Tablets per bottle, Rx Only, Manufactured for Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, India, NDC 16729-450-15.

This recall is currently active, issued October 15, 2025. It was issued by Accord Healthcare, Inc..

Company
Accord Healthcare, Inc.
Recall Initiated
September 16, 2025
Posted
October 15, 2025
Recall Number
D-0006-2026
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
54,432 bottles
Firm Location
Raleigh, NC, United States
Official Source
View on FDA website ↗

Reason for Recall

Subpotent: During long term stability testing of Levothyroxine Sodium Tablets USP for 88 mcg, the assay content was observed below the approved specification range.

Distribution

Nationwide in the US

Lot / Code Info

Lot # D2300045, Exp 12/31/2025.

More recalls by Accord Healthcare, Inc.

View all recalls by this company →

Other recent Class II Drug recalls